Washington · 88187

Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in Washington

Washington Medicare Avg
$27.92
3% above national avg
National Medicare Avg
$27.09
All states combined
Billed Charge (WA)
$159.13
What providers submit
Est. Commercial (WA)
$84.09
National avg: $78.17
Est. Cash / Self-Pay (WA)
$70.60
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

490
Services in WA
63
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Washington

Provider Medicare Services
Hematologics Inc $27.98 18
Laboratory Corporation Of America $25.13 13

Washington Pricing in Context

In Washington, CPT code 88187 (Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers) carries an average Medicare payment of $27.92 — 3% above the national benchmark of $27.09. 63 providers across the state submitted claims for this procedure in 2023, performing 490 total services. Individual payments in WA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Washington is $159.13, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Washington sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Washington lands near $84.09, with self-pay cash prices typically around $70.60. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cost in Washington?

The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in Washington is $27.92, which is 3% above the national average of $27.09. Providers in WA typically bill $159.13 for this procedure.

What does Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cost with insurance in Washington?

With commercial insurance in Washington, Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers costs an estimated $84.09. Without insurance, the estimated cash price is $70.60. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in Washington?

63 providers in Washington billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in 2023, performing 490 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cheaper in Washington than the national average?

No — Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers costs 3% above the national average in Washington. The state average Medicare payment is $27.92 compared to $27.09 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial